Gilead Sciences, Inc. (GILD) Discusses Proposed Acquisitions of Tubulis, Ouro and Arcellx and Strategic Pipeline Growth Transcript
Comply with Play Earnings NamePlay Earnings Name Gilead Sciences, Inc. (GILD) Discusses Proposed Acquisitions of Tubulis, Ouro and Arcellx and Strategic Pipeline Growth April 7, 2026 4:30 PM EDT Firm Individuals Jacquie Ross – Senior Vice President of Treasury and Investor RelationsDaniel O’Day – Chairman & CEODietmar Berger – Chief Medical OfficerCindy Perettie – Govt […]








